U.S.
$99.49+2.36%
报价 2026-11-06
市值
$1.48B
EV
$1.64B
PE (TTM)
493.9x
预期 PE (FY2026)
34.9x
52 周区间距高点 0.0%
$59.00$99.49
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 2.68 → 3.37（1.3x） | 29.5 |
| FY+32028-12 | 1.2x | 2.68 → 3.69（1.4x） | 26.9 |
毛利率 19% · TTM 收入 $838M · 基数 EPS 2.68（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| USPHU.S. Physical Therapy, Inc. | $1.48B | +2.4% | +9.1% | 19.6% | 493.9x | 16.3x | 19.9x | |
| NEOGNeogen Corporation | $2.57B | +0.7% | +3.6% | 47.4% | – | 31.6x | 54.7x | |
| ZBIOZenas BioPharma, Inc. | $1.84B | +9.0% | -47.8% | 0% | – | – | – | |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | $1.72B | +0.9% | +51.5% | 56.5% | – | – | – | 高增长 |
| ASTHAstrana Health, Inc. | $1.71B | -11.6% | +26.0% | 10.7% | 45.8x | 12.9x | 11.9x | |
| HCSGHealthcare Services Group, Inc. | $1.64B | -3.3% | +6.1% | 16.8% | 16.3x | 11.6x | 15.2x | |
| CNMDCONMED Corporation | $1.53B | -2.5% | -0.4% | 56.4% | 21.3x | 10.9x | 11.6x | |
| PNTGThe Pennant Group, Inc. | $1.27B | -9.1% | +27.3% | 13.3% | 35.0x | 23.3x | 49.5x | |
| GDRXGoodRx Holdings, Inc. | $1.2B | +0.6% | +0.6% | 89.5% | 66.7x | 8.4x | 8.2x | |
| 同行中位数 | – | – | +4.8% | 32.1% | 35.0x | 12.2x | 13.5x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $214.1M | $198.3M | $202.7M | $164M | $164.2M | $152.5M | $180.4M | $168M |
| Gross Margin | 19.6% | 14.5% | 20.7% | 22.5% | 25.4% | 20.4% | 18.7% | 17.3% |
| Operating Margin | 10.3% | 7.5% | 10.9% | 15.4% | 15.2% | 12.9% | 8.1% | 8.8% |
| Net Income | $1.6M | $-4.3M | $-10.5M | $7.2M | $8.8M | $9.9M | $7.4M | $5.5M |
| Diluted EPS | 0.25 | -0.12 | -0.44 | 0.48 | 0.58 | 0.8 | 0.52 | 0.39 |
| Operating Cash Flow | $34.2M | $4M | $24.9M | $19.9M | $34.9M | $-4.7M | $19.4M | $22.1M |